Back to search

Article

Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase

2020-08-10

Abstract excerpt

<h4>ABSTRACT</h4> The raging COVID-19 pandemic caused by SARS-CoV2 has infected millions of people and killed several hundred thousand patients worldwide. Currently, there are no effective drugs or vaccines available for treating coronavirus infections. In this study, we have focused on the SARS-CoV2 helicase (Nsp13), which is critical for viral replication and the most conserved non-structural protein within the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6bc8b1a4-1b63-5102-af3d-f3f33a74d762
DOI
10.1101/2020.08.09.243246
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 HelicaseDOI 10.1101/2020.08.09.243246
Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 HelicaseSemantic proximity
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugsSemantic proximity
Therapeutic potential of compounds targeting SARS-CoV-2 helicaseSemantic proximity
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).Semantic proximity
High throughput screening for SARS-CoV-2 helicase inhibitorsSemantic proximity
Novel inhibitors against COVID-19 main protease suppressed viral infectionSemantic proximity
What a twist: structural biology of the SARS-CoV-2 helicase nsp13Semantic proximity
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Semantic proximity
High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent InhibitorSemantic proximity
Genetic Variability of the SARS-CoV-2 PocketomeSemantic proximity
Potential Inhibitors Targeting RNA-Dependent RNA Polymerase Activity (NSP12) of SARS-CoV-2Semantic proximity
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?Semantic proximity
Select a neighboring publication to make it the new centre.